Experiments were carried out in mutant 129/SvEv mice lacking the endothelin-A (ET(A))-receptor to determine whether endothelin-1 (ET-1), acting as a messenger for oxygen constriction, is responsible for closure of the ductus arteriosus at birth. The isolated ductus from ET(A) -/- fetuses, unlike that from ET(A) +/+ littermates, contracted marginally to oxygen and ET-1 but responded to a thromboxane analog. In vivo, reduction in ductus lumen was equally pronounced in tracheotomized ET(A) -/- and ET(A) +/+ newborns. Conversely, no such vessel narrowing was seen in hyperoxic ET(A), -/- fetuses, although it occurred in ET(A) +/+ littermates. Notwithstanding the uneven behaviour of the ductus in vitro and in vivo, no ET(A) genotype-related difference was noted in the morphology of the vessel on both light and electron microscopy. We conclude that ET-1 mediates the ductus constriction to oxygen. Without ET-1, however, the vessel still closes postnatally probably as a result of the withdrawal of the relaxing influence of prostaglandin E2 (PGE2).

Download full-text PDF

Source
http://dx.doi.org/10.1097/00005344-200036051-00025DOI Listing

Publication Analysis

Top Keywords

eta -/-
12
eta +/+
12
closure ductus
8
ductus arteriosus
8
-/- fetuses
8
+/+ littermates
8
oxygen et-1
8
eta
7
ductus
6
deletion endothelin-a-receptor
4

Similar Publications

Background: Cancer is a leading cause of global mortality, accounting for nearly 10 million deaths in 2020. This is projected to increase by more than 60% by 2040, particularly in low- and middle-income countries. Yet, palliative and psychosocial oncology care is very limited in these countries.

View Article and Find Full Text PDF

Middle ear secretions following spontaneous CSF leak repair may represent effusion rather than CSF leak.

Eur Arch Otorhinolaryngol

December 2024

Departments of Otolaryngology-Head and Neck Surgery and Maxillofacial Surgery, School of Medicine, Tel Aviv Sourasky Medical Center, Tel-Aviv University, Tel Aviv, 6423907, Israel.

Objective: To characterize middle ear (ME) effusion still present 2 months after repair surgery for spontaneous cerebrospinal fluid (CSF) leak via the temporal bone (TB).

Study Design: A retrospective chart review (2011-2022).

Setting: Tertiary referral academic center.

View Article and Find Full Text PDF

Predictors of Delays in the Management of Idiopathic Sudden Sensorineural Hearing Loss.

Laryngoscope

February 2025

Department of Otolaryngology-Head and Neck Surgery and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Objective: To study predictors of delayed presentation, diagnosis, and treatment of idiopathic sudden sensorineural hearing loss (ISSNHL).

Study Design: Retrospective medical chart review and patient telephone survey.

Setting: Tertiary medical center.

View Article and Find Full Text PDF

Recovery rate after acute acoustic trauma: a case series and meta-analysis.

Eur Arch Otorhinolaryngol

December 2024

Department of Otolaryngology-Head and Neck Surgery and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, 6423906, Tel Aviv, Israel.

Article Synopsis
  • Steroids are a key treatment for acute acoustic trauma (AAT), but the overall recovery rate is not well defined.
  • A study analyzed cases from 2012 to 2022, combining original case data with a systematic review of existing literature to evaluate treatment outcomes.
  • Results showed about 70% of ears experienced some recovery with steroids, while around 30% achieved full recovery if treatment began within the first two weeks post-injury.
View Article and Find Full Text PDF

Idiopathic sudden sensorineural hearing loss after COVID-19 vaccination: a systematic review and meta-analysis.

Eur Arch Otorhinolaryngol

December 2024

Department of Otolaryngology-Head and Neck Surgery and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Objective: To provide pooled analyses on the association between COVID-19 vaccine and the incidence of idiopathic sudden sensorineural hearing loss (ISSNHL).

Data Sources: "Medline" via "PubMed", "EMBASE", and "Google scholar".

Review Methods: Data sources were inspected from January 2020 to January 2024 using search terms relevant to vaccines for COVID-19.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!